Carmell Corp. () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1292095,
    "name": "Carmell Corp.",
    "stock_name": "Carmell Corp.",
    "full_name": "Carmell Corp.",
    "name_url": "stocks-analysis/carmell-corp",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "0.39",
    "chg": 0.02,
    "chgp": "5.16%",
    "dir": 1,
    "prev_price": "0.37",
    "mcapval": "4.47",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US1429221039",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "1.29 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/carmell-corp-1292095-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Carmell Corp. Stock Plummets to New 52-Week Low of $0.82",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/carmell-corp-stock-plummets-to-new-52-week-low-of-082-3531598",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/CarmellCorp_priceRelatedfactors_3531598.png",
        "date": "2025-09-18 13:30:45",
        "description": "Carmell Corp., a microcap in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low, reflecting a difficult year with a significant stock price decline. The company, with a market cap of approximately USD 4 million, has not reported earnings and shows a moderate debt-to-equity ratio."
      },
      {
        "title": "Carmell Corp. Stock Plummets to New 52-Week Low of $1.12",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/carmell-corp-stock-plummets-to-new-52-week-low-of-112-3525977",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/CarmellCorp_priceRelatedfactors_3525977.png",
        "date": "2025-09-17 15:26:31",
        "description": "Carmell Corp., a microcap in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low, reflecting a significant decline over the past year. With a market capitalization of around USD 4 million, the company is currently loss-making and faces valuation concerns despite a high return on equity."
      },
      {
        "title": "Carmell Corp. Hits New 52-Week Low at $1.21 Amidst Declining Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/carmell-corp-hits-new-52-week-low-at-121-amidst-declining-performance-3519702",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/CarmellCorp_priceRelatedfactors_3519702.png",
        "date": "2025-09-16 11:38:06",
        "description": "Carmell Corp., a microcap in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low, reflecting a challenging year with a significant stock price decline. The company reports negative earnings, a negative book value, and consistent losses, raising concerns about its financial stability and future prospects."
      }
    ],
    "total": 7,
    "sid": "1292095",
    "stock_news_url": "https://www.marketsmojo.com/news/carmell-corp-1292095"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Carmell Corp. Stock Plummets to New 52-Week Low of $0.82

2025-09-18 13:30:45

Carmell Corp., a microcap in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low, reflecting a difficult year with a significant stock price decline. The company, with a market cap of approximately USD 4 million, has not reported earnings and shows a moderate debt-to-equity ratio.

Carmell Corp. Stock Plummets to New 52-Week Low of $1.12

2025-09-17 15:26:31

Carmell Corp., a microcap in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low, reflecting a significant decline over the past year. With a market capitalization of around USD 4 million, the company is currently loss-making and faces valuation concerns despite a high return on equity.

Carmell Corp. Hits New 52-Week Low at $1.21 Amidst Declining Performance

2025-09-16 11:38:06

Carmell Corp., a microcap in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low, reflecting a challenging year with a significant stock price decline. The company reports negative earnings, a negative book value, and consistent losses, raising concerns about its financial stability and future prospects.

View All News